Innovating Pharmaceutical Therapies
Pioneering the world’s first prescription CBD for social anxiety disorder.
Extraordinary Leadership. Unparalleled Experience.
EmpowerPharm is conducting clinical studies using cannabidiol (CBD) for prescription medicines to treat social anxiety disorder.
EmpowerPharm Inc. is a Canadian owned pharmaceutical company dedicated to creating a company driven for social impact. Leveraging our diverse expertise as industry leaders, we specialize in the research, development, manufacturing, and commercialization of medicines with novel formulations in our state-of-the-art GMP pharmaceutical facility located in Burlington, Canada.
Our Mission: We are empowered to develop and commercialize products through improved drug delivery technology that will improve patient therapeutic outcomes and quality of life
CurrentNews
EmpowerPharm Inc. Announces First Patient Dosed in a Phase II Study Evaluating Empower CBD™ for the Treatment of Social Anxiety Disorder
EmpowerPharm Inc a clinical-stage life sciences company focused on research and clinical development announced today that the first patient has been dosed in their Company-sponsored Phase II clinical study.
EmpowerPharm Inc. Announces First Patient Enrolled in a Phase II Study Evaluating Empower CBD™ for the Treatment of Social Anxiety Disorder
EmpowerPharm Inc a clinical-stage life sciences company focused on research and clinical development announced today that the first patient has been enrolled in their Company-sponsored Phase II clinical study.
EmpowerPharm Inc. welcomes Terri-Jean (TJ) Geddis
TJ is a commercial leader with over 25 years of experience in both the pharmaceutical and biotech industries. She started her career at larger companies such as Eli Lilly and with her entrepreneurial mindset, gravitated to smaller, Canadian start-up organizations such as Alexion and Mitsubishi Tanabe Pharma.
EmpowerPharm Inc. Announces First Patient Dosed in a Phase II Study Evaluating Empower CBD™ for the Treatment of Social Anxiety Disorder
EmpowerPharm Inc a clinical-stage life sciences company focused on research and clinical development announced today that the first patient has been dosed in their Company-sponsored Phase II clinical study.
EmpowerPharm Inc. Announces First Patient Enrolled in a Phase II Study Evaluating Empower CBD™ for the Treatment of Social Anxiety Disorder
EmpowerPharm Inc a clinical-stage life sciences company focused on research and clinical development announced today that the first patient has been enrolled in their Company-sponsored Phase II clinical study.